Cargando…

Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity

OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation in the airway and lung. A protease–antiprotease imbalance has been suggested as a possible pathogenic mechanism for COPD. We evaluated the relationship between matrix metalloproteinase (MMP) levels and C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koo, Hyeon-Kyoung, Hong, Yoonki, Lim, Myoung Nam, Yim, Jae-Joon, Kim, Woo Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890689/ https://www.ncbi.nlm.nih.gov/pubmed/27313452 http://dx.doi.org/10.2147/COPD.S103281

Ejemplares similares

Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
por: Fujimoto, Keisaku, et al.
Publicado: (2011)

Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers
por: O’Brien, Michael E., et al.
Publicado: (2019)

Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases
por: Ostridge, Kristoffer, et al.
Publicado: (2016)

Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
por: Kim, Junghyun, et al.
Publicado: (2017)

Implications of Emphysema and Lung Function for the Development of Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Hong, Yoonki, et al.
Publicado: (2016)

Sputum matrix metalloproteinase-9 is associated with the degree of emphysema on computed tomography in COPD
por: Chaudhuri, Rekha, et al.
Publicado: (2013)

Association between plasma sRAGE and emphysema according to the genotypes of AGER gene
por: Sin, Sooim, et al.
Publicado: (2022)

Expression of Matrix Metalloproteinase-1 in Alveolar Macrophages, Type II Pneumocytes, and Airways in Smokers: Relationship to Lung Function and Emphysema
por: Wallace, Alison M., et al.
Publicado: (2014)

A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups
por: Kim, Suhyun, et al.
Publicado: (2017)

Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema
por: D’Armiento, Jeanine M., et al.
Publicado: (2013)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Lack of Association between Matrix Metalloproteinase 8 Promoter Polymorphism and Bronchiectasis in Koreans
por: Lee, Jiwon, et al.
Publicado: (2007)

Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2020)

Gender-Dependent Differences in Plasma Matrix Metalloproteinase-8 Elevated in Pulmonary Tuberculosis
por: Sathyamoorthy, Tarangini, et al.
Publicado: (2015)

Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2022)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Elevated Plasma Matrix Metalloproteinase 8 Associates With Sputum Culture Positivity in Pulmonary Tuberculosis( )
por: Walker, N F, et al.
Publicado: (2022)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Acute exacerbations of COPD are associated with significant activation of matrix metalloproteinase 9 irrespectively of airway obstruction, emphysema and infection
por: Papakonstantinou, Eleni, et al.
Publicado: (2015)

Matrix Metalloproteinases in Chronic Obstructive Pulmonary Disease
por: Christopoulou, Maria-Elpida, et al.
Publicado: (2023)

Quantitative computed tomography features and clinical manifestations associated with the extent of bronchiectasis in patients with moderate-to-severe COPD
por: Bak, So Hyeon, et al.
Publicado: (2018)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Association of incidental emphysema with annual lung function decline and future development of airflow limitation
por: Koo, Hyeon-Kyoung, et al.
Publicado: (2016)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

The Influence of Asian Dust, Haze, Mist, and Fog on Hospital Visits for Airway Diseases
por: Park, Jinkyeong, et al.
Publicado: (2015)

Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L
por: Xu, Xia, et al.
Publicado: (2023)

PULMONARY EMPHYSEMA
Publicado: (1957)

Differential Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Thioacetamide-Induced Chronic Liver Injury
por: Park, Soo Young, et al.
Publicado: (2010)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Inhaled bronchodilators and acute myocardial infarction: a nested case-control study
por: Lee, Chang-Hoon, et al.
Publicado: (2017)

Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis
por: Pardo, Annie, et al.
Publicado: (2016)

Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression
por: Inoue, Ryo, et al.
Publicado: (2023)

Spirometry and Bronchodilator Test
por: Sim, Yun Su, et al.
Publicado: (2017)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis
por: Jones, Tiffanie K., et al.
Publicado: (2022)

Correction: Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L
por: Xu, Xia, et al.
Publicado: (2023)

Helminth Coinfection Is Associated With Enhanced Plasma Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Tuberculous Lymphadenitis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2021)

Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
por: Beránek, Michal, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ji5ovlng3kqnlcsenlj920dufu